Search fresh public links, source activity, and post angles for 340B.
Fresh curated links around 340B are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
That is the argument made by Ike Brannon and Anthony Lo Sasso in a recent Health Affairs Forefront article. 340B allows hospitals serving low income communities to purchase pharmac...
For more than three decades, the 340B Drug Pricing Program... The post 340B Rebate Model: Building Dispute-Ready, Audit-Ready Operations with Better Data and Controls appeared firs...
By Bryce Platt, PharmD Minnesota’s new 340B data reveal a growing disconnect between the program’s size and the value Minnesotans receive in return. In 2024, nonprofit hospitals...
The decision at least temporarily rolls back a 2013 policy update restricting some 340B hospitals from using a group purchasing organization to make initial purchases of covered ou...
Key Takeaways - HRSA has extended the deadline for comments on its proposed 340B rebate model pilot program to April 20, 2026. Covered entities have a limited window to submit deta...
Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 3...
AbbVie is spearheading a new battle in pharma's long-running fight to reform the federal government’s 340B drug discount program.
Key Takeaways HRSA has extended the deadline for comments on its proposed 340B rebate model pilot program to April 20, 2026. Covered entities have a limited window to submit detai...
The U.S. District Court for the District of Columbia March 31 vacated a Health Resources and Services Administration policy instituted in 2013 that restricted how certain 340B hosp...
Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 3...
Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 3...
Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 3...
Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 3...
Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 3...
Lawsuits filed by nonprofit hospitals accuse the company's pharmacy benefit manager, specialty pharmacy and third-party administrator of working together to artificially depress ra...
The U.S. Court of Appeals for the 5th Circuit April 9 affirmed rulings by a Mississippi district court that rejected requests by Novartis and PhRMA to enjoin enforcement of the sta...
Join Dr. Adam J. Fein, president of Drug Channels Institute (DCI) and the editor of Drug Channels, for his latest exclusive video webinar: 340B in 2026: Market Shifts, Policy Bat...
Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 3...
Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 3...
The 340B Drug Discount Program was created to help low-income patients. Instead, it too often helps multibillion dollar “non-profit” hospitals to fund ad campaigns, pad executive p...
Three health systems — Mount Sinai, Michigan Medicine and the University of Kansas Health System — are suing CVS Health, alleging its pharmacy benefit manager diverted roughly $250...
Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 3...
The Washington Post yesterday published a letter to the editor from AHA President and CEO Rick Pollack responding to an April 18 editorial criticizing the 340B Drug Pricing Program...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.